99 related articles for article (PubMed ID: 10965899)
1. Identification of an osteogenic protein-1 (bone morphogenetic protein-7)-responsive element in the promoter of the rat insulin-like growth factor-binding protein-5 gene.
Yeh LC; Lee JC
Endocrinology; 2000 Sep; 141(9):3278-86. PubMed ID: 10965899
[TBL] [Abstract][Full Text] [Related]
2. Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms.
Yeh LC; Adamo ML; Duan C; Lee JC
J Cell Physiol; 1998 Apr; 175(1):78-88. PubMed ID: 9491783
[TBL] [Abstract][Full Text] [Related]
3. Osteogenic protein-1 up-regulation of the collagen X promoter activity is mediated by a MEF-2-like sequence and requires an adjacent AP-1 sequence.
Harada S; Sampath TK; Aubin JE; Rodan GA
Mol Endocrinol; 1997 Nov; 11(12):1832-45. PubMed ID: 9369451
[TBL] [Abstract][Full Text] [Related]
4. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.
Yeh LC; Adamo ML; Olson MS; Lee JC
Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928
[TBL] [Abstract][Full Text] [Related]
5. Activation of the insulin-like growth factor-binding protein-5 promoter in osteoblasts by cooperative E box, CCAAT enhancer-binding protein, and nuclear factor-1 deoxyribonucleic acid-binding sequences.
Ji C; Chen Y; Centrella M; McCarthy TL
Endocrinology; 1999 Oct; 140(10):4564-72. PubMed ID: 10499512
[TBL] [Abstract][Full Text] [Related]
6. Osteogenic protein-1 stimulates production of insulin-like growth factor binding protein-3 nuclear transcripts in human osteosarcoma cells.
Hayden JM; Strong DD; Baylink DJ; Powell DR; Sampath TK; Mohan S
Endocrinology; 1997 Oct; 138(10):4240-7. PubMed ID: 9322936
[TBL] [Abstract][Full Text] [Related]
7. Osteogenic protein-1-mediated insulin-like growth factor gene expression in primary cultures of rat osteoblastic cells.
Yeh LC; Adamo ML; Kitten AM; Olson MS; Lee JC
Endocrinology; 1996 May; 137(5):1921-31. PubMed ID: 8612532
[TBL] [Abstract][Full Text] [Related]
8. Identification of an osteogenic protein-1 responsive element in the aggrecan promoter.
Yeh LC; Lee JC
Biochem Biophys Res Commun; 2004 Oct; 323(1):223-8. PubMed ID: 15351725
[TBL] [Abstract][Full Text] [Related]
9. Co-transfection with the osteogenic protein (OP)-1 gene and the insulin-like growth factor (IGF)-I gene enhanced osteoblastic cell differentiation.
Yeh LC; Lee JC
Biochim Biophys Acta; 2006 Jan; 1763(1):57-63. PubMed ID: 16364466
[TBL] [Abstract][Full Text] [Related]
10. Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells.
Knutsen R; Honda Y; Strong DD; Sampath TK; Baylink DJ; Mohan S
Endocrinology; 1995 Mar; 136(3):857-65. PubMed ID: 7532581
[TBL] [Abstract][Full Text] [Related]
11. Activation of the insulin-like growth factor binding protein-5 promoter by parathyroid hormone in osteosarcoma cells requires activation of an activated protein-2 element.
Erclik MS; Mitchell J
J Mol Endocrinol; 2005 Jun; 34(3):713-22. PubMed ID: 15956342
[TBL] [Abstract][Full Text] [Related]
12. Identification of cis-elements mediating the stimulation of rat insulin-like growth factor-binding protein-1 promoter activity by dexamethasone, cyclic adenosine 3',5'-monophosphate, and phorbol esters, and inhibition by insulin.
Suh DS; Ooi GT; Rechler MM
Mol Endocrinol; 1994 Jun; 8(6):794-805. PubMed ID: 7523864
[TBL] [Abstract][Full Text] [Related]
13. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of BMP receptor synthesis by antisense oligonucleotides attenuates OP-1 action in primary cultures of fetal rat calvaria cells.
Yeh LC; Betchel KP; Lee JC
J Bone Miner Res; 1998 Dec; 13(12):1870-9. PubMed ID: 9844105
[TBL] [Abstract][Full Text] [Related]
15. Osteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts.
Yeh LC; Unda R; Lee JC
J Cell Physiol; 2000 Oct; 185(1):87-97. PubMed ID: 10942522
[TBL] [Abstract][Full Text] [Related]
16. Curcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C/EBPalpha during oral cancer suppression.
Chang KW; Hung PS; Lin IY; Hou CP; Chen LK; Tsai YM; Lin SC
Int J Cancer; 2010 Jul; 127(1):9-20. PubMed ID: 20127863
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone modulates insulin regulation of hepatic insulin-like growth factor binding protein-1 transcription.
Hu M; Robertson DG; Murphy LJ
Endocrinology; 1996 Sep; 137(9):3702-9. PubMed ID: 8756536
[TBL] [Abstract][Full Text] [Related]
18. Static magnetic fields-induced bone sialoprotein (BSP) expression is mediated through FGF2 response element and pituitary-specific transcription factor-1 motif.
Shimizu E; Matsuda-Honjyo Y; Samoto H; Saito R; Nakajima Y; Nakayama Y; Kato N; Yamazaki M; Ogata Y
J Cell Biochem; 2004 Apr; 91(6):1183-96. PubMed ID: 15048873
[TBL] [Abstract][Full Text] [Related]
19. Characterization of receptors for osteogenic protein-1/bone morphogenetic protein-7 (OP-1/BMP-7) in rat kidneys.
Bosukonda D; Shih MS; Sampath KT; Vukicevic S
Kidney Int; 2000 Nov; 58(5):1902-11. PubMed ID: 11044210
[TBL] [Abstract][Full Text] [Related]
20. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
